Autor: |
Bialecki RA; Respiratory, Inflammatory, and Neurological Diseases Research Section, ZENECA Pharmaceuticals, Wilmington, Delaware 19850-5437, USA., Fisher CS, Murdoch WW, Barthlow HG, Bertelsen DL |
Jazyk: |
angličtina |
Zdroj: |
The American journal of physiology [Am J Physiol] 1997 Feb; Vol. 272 (2 Pt 1), pp. L211-8. |
DOI: |
10.1152/ajplung.1997.272.2.L211 |
Abstrakt: |
The receptors mediating arterial smooth muscle contraction to endothelins (ET) differ among species and origin of vascular bed. We characterized ET receptors mediating contraction of endothelium-denuded human intralobar pulmonary artery (hIPA) and rat intralobar (rIPA) and extralobar left branch (rLPA) pulmonary artery with ET-1, ET-2, ET-3, sarafotoxin S6c, sarafotoxin S6b, and ET receptor antagonists in vitro. Rat aorta was studied for comparison. Each vascular segment showed concentration-dependent contraction with a rank order sensitivity (pD2) profile of ET-1 > or = ET-2 = sarafotoxin S6b > ET-3. Maximum contraction to ET-1 was greater than to sarafotoxin S6c in all preparations. Responses of rIPA and rLPA to sarafotoxin S6c were conspicuous when compared with hIPA or aorta. The ET(A) receptor blockers BQ-123 and BMS-182874 competitively antagonized ET-1 responses of hIPA and aorta, but not rLPA. The ET(B) receptor antagonist BQ-788 attenuated contractions of rIPA and rLPA to ET-3 and sarafotoxin S6c, respectively. In conclusion, ET(B)-mediated contraction of endothelium-denuded conduit pulmonary arteries varies among species and may contribute more to contraction of rIPA and rLPA than of hIPA and aorta, although maximum ET(B)-mediated contraction is smaller than that mediated by the ET(A) receptor. |
Databáze: |
MEDLINE |
Externí odkaz: |
|